Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Shares Issued (2016 - 2025)

Historic Shares Issued for iBio (IBIO) over the last 15 years, with Q4 2025 value amounting to $55.9 million.

  • iBio's Shares Issued rose 20978.94% to $55.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $55.9 million, marking a year-over-year increase of 25850.34%. This contributed to the annual value of $113.0 for FY2025, which is 9999.75% down from last year.
  • According to the latest figures from Q4 2025, iBio's Shares Issued is $55.9 million, which was up 20978.94% from $30.0 recorded in Q3 2025.
  • In the past 5 years, iBio's Shares Issued registered a high of $55.9 million during Q4 2025, and its lowest value of -$6.7 million during Q2 2024.
  • Moreover, its 4-year median value for Shares Issued was $77000.0 (2021), whereas its average is $5.7 million.
  • Per our database at Business Quant, iBio's Shares Issued tumbled by 9998.23% in 2021 and then skyrocketed by 1796000.0% in 2024.
  • iBio's Shares Issued (Quarter) stood at $77000.0 in 2021, then grew by 29.87% to $100000.0 in 2023, then soared by 17960.0% to $18.1 million in 2024, then surged by 209.79% to $55.9 million in 2025.
  • Its Shares Issued was $55.9 million in Q4 2025, compared to $30.0 in Q3 2025 and -$1.1 million in Q2 2025.